Abstract Traumatic brain injury is usually assessed with the Glasgow coma scale (GCS), CT, or MRI. After such injury, the injured brain tissue is characterised by calcium mediated neuronal damage and inflammation. Positron emission tomography with the isotope cobalt-55 (Co-PET) as a calcium tracer enables imaging of affected tissue in traumatic brain injury.
The aim was to determine whether additional information can be gained by Co-PET in the diagnosis of moderate traumatic brain injury and to assess any prognostic value of Co-PET.
Five patients with recent moderately severe traumatic brain injury were studied. CT was performed on the day of admission, EEG within one week, and MRI and Co-PET within four weeks of injury. Clinical assessment included neurological examination, GCS, neuropsychological testing, and Glasgow outcome scale (GOS) after one year.
Co-PET showed focal uptake that extended beyond the morphological abnormalities shown by MRI and CT, in brain regions that were actually diagnosed with EEG. Thus Co-PET is potentially useful for diagnostic localisation of both structural and functional abnormalities in moderate traumatic brain injury. Traumatic brain injury mostly affects young people and can alter physical functioning, cognitive skills such as memory, and personality.' Severity of traumatic brain injury is assessed with the Glasgow coma scale (GCS), which determines the level of consciousness in terms of eye opening, verbal response, and motor response.' 2 Traumatic brain injury is categorised as mild, moderate, or severe depending on this GCS assessment. Even mild (GCS 13-15) traumatic brain injury with transient symptoms can cause delayed neuronal and cellular deterioration and considerable long term deficits.' Moderate traumatic brain injury (GCS 9-12) often involves lasting, subtle, changes in personality and cognitive performance.' Imaging techniques such as CT, MRI, SPECT, and emission PET have been used to diagnose severity of traumatic brain injury and to predict clinical outcome, showing morphological changes, regional cerebral blood flow (rCBF), and metabolism of the injured brain. 7 Damage by closed traumatic brain injury (without penetration of the skull) can be primary or secondary. Although primary injury (direct mechanical damage to cells and axons at the moment of injury) accounts for the immediate brain damage (acute neuronal death), secondary injury (pathophysiological events as a result of either global or focal ischaemia) arises often from late onset progressive neuronal damage (delayed neuronal death).89 Both acute and delayed neuronal death have been attributed to calcium overload and inflammatory processes.910
To detect and define traumatic tissue damaged by brain injury we used cobalt -55 with PET (Co-PET) to monitor the calcium mediated damage with PET. We have previously used Co-PET to visualise brain infarcts and multiple sclerosis, independently of integrity of the blood-brain barrier." ' 12 The present pilot study included five patients with traumatic brain injury of moderate severity who underwent clinical examination, neuropsychological testing, EEG, CT, MRI, and Co-PET.
Patients and methods
Five patients who sustained closed traumatic brain injury of moderate severity (GCS 9-12 or GCS 13-15 with post-traumatic amnesia for more than three days), subsequently admitted in a six month period to the department of neurology of the Groningen University Hospital were studied. The study was approved by the medical ethics committee of the hospital. 
Results
The table summarises the clinical, CT, EEG, MRI, and Co-PET data. In all patients neuropsychological impairments were found four to six weeks after injury, deficits in verbal and non-verbal memory being the most common.
In patient A, brain abnormalities were evident on Co-PET and EEG. This patient recovered well and had no persistent EEG abnormalities after one year. Patient B had abnormalities on Co-PET, CT, MRI, and EEG both post-trauma and after one year. This patient had a skull fracture and showed full recovery. Patient C had abnormal Co-PET, CT, and MRI. The Co-PET showed cobalt accumulation in the left tempoal region that was 3 7 times the activity in the mirror region (figure). The EEG disturbances persisted throughout the follow up period of one year. This patient had several residual complaints after one year. Patient D showed structural abnormalities on CT, including a skull Cobalt-55 positron emission tomography in traumatic brain injury: a pilot study Clinical, CT, EEG, MRI, and Co-PET data on five patients (A-E) with closed traumatic brain injury Right temporal Right temporal Right frontalRight temporal 2-9 450 temporal GCS = Glasgow coma scale for assessment of level of consciousness with a total severity score from 3-15 (day of admission); PTA = post traumatic amnesia (days); GOS = extended version of the Glasgow outcome scale on a score from 0 (poor outcome) to 8 (excellent outcome) (one year after traumatic brain injury); CT was on day of admission; EEG was within one week of traumatic brain injury; MRI and Co-PET were between three and four weeks after traumatic brain injury; CER = cobalt enhancement ratio (quotient of the mean average cobalt uptake in arbitrary units in the injured tissue v the non-affected mirror brain); CCL = cobalt contusion load: representing the total amount of radioactivity accumulated in an affected volume of the brain as the ratio of radioactivity in the same volume in the contralateral part of the brain; NA = no abnormalities.
fracture. Both Co-PET and EEG showed abnormalities that were not in accordance with CT findings. The follow up EEG was normal and the patient recovered well. Patient E had abnormalities on Co-PET, CT, and MRI. The EEG findings were abnormal both post-trauma and on follow up. This patient was admitted to a psychiatric hospital.
Discussion
All patients made a fairly good recovery in terms of both GOS and neuropsychological testing. In all patients, neuropsychological testing (baseline), Co-PET, and EEG (after trauma) showed focal abnormalities in the affected frontal and temporal brain regions. By contrast, CT and MRI did not detect lesions in every case. Thus the lack of (structural) abnormalities on CT or MRI does not rule out the presence of (transient functional) brain damage (EEG; Co-PET) and consequent inpairment in neuropsychological testing, as seen in patients A and D. In these two patients the abnormalities on EEG disappeared after one year and the outcome of the patients was good. The other three patients (B, C, E) had persistent EEG abnormalities and initial structural damage on CT and MRI. Patients C and E had a suboptimal outcome in clinical terms. Patients B and D both had a skull fracture, which may relate to their good outcome despite evident abnormalities on several imaging modalities.
There was no relation between neuroimaging data and clinical data (table) or neuropsychological testing data, either quantitatively or on localisation. Although all patients had frontal and temporal brain lesions, these were not those expected from the neuropsychological testing profiles. Apart from the limited sample size of our pilot study, the lack of a relation could be because of the broadly distributed cerebral representation of many cognitive functions (except perhaps memory).3 The neuropsychological testing battery as applied here is in fact not meant to localise lesions, but instead is aimed at the most common cognitive impairments resulting from traumatic brain injury, functions that have a limited localisation value.
Secondary (ischaemic) injury after traumatic brain injury is a delayed phenomenon triggered by the primary (mechanical) injury, that begins a few hours after trauma and progresses over several days. The tolerance of neurons for primary injury is variable and depends on site and size of the impact and the mechanics of trauma. Secondary injury may rather be determined by residual rCBF, duration of ischaemia, and selective ischaemic vulnerability, differing from neuron to neuron and mediated through calcium channels. The fate of contusional ischaemic tissue (postischaemic recovery v progressive metabolic derangement) is thus determined by both rCBF and calcium influx. Functionally impaired but potentially viable injured tissue is characterised by increased calcium influx up to 48 hours after traumatic brain injury. Thereafter, the calcium mediated inflammatory process may become an important pathogenic factor. The infiltration of these processes may characterise the contusional tissue up to five weeks after onset of traumatic brain injury. Thus cobalt may both be a measure for calcium mediated (ir)reversible damage to neurons and a marker for inflammation. Cobalt in blood exists in a free unbound form, in a protein bound form (mostly), and in a cell bound form (leucocytes). The basic (hypothetical) mechanism of detection in Co-PET is extravasation of intravenous cobalt into the affected brain areas, in either free (intact blood-brain barrier) or protein-bound form (disrupted blood-brain barrier). In addition, cobalt accumulation can be due to leucocyte infiltration into the affected area and the process of new capillary formation, creating a newly formed "cobalt blood pool."
In conclusion, Co-PET is able to show the site and size of brain damage in patients with moderate traumatic brain injury. These abnormalities may be either functional or structural.
It may confirm and especially localise EEG findings. Also, Co-PET may confirm findings from CT or MRI. To determine whether there is any additional diagnostic or prognostic value and to ascertain the most appropriate time window after injury appropriate for monitoring ischaemic damage needs further study in a larger series of patients. It would be of interest to perform serial Co-PET at regular intervals, to add rCBF imaging modalities in
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Thymus serpyllum (wild thyme)
Wild thyme-a creeping shrub of the mint family-was, in former times, known as a valuable medicinal plant and as a "certain remedy for that troublesome complaint, the nightmare". It was also used to treat "headache due to inebriation" and "nervous disorders". The plant contains thymol, which has been used as a disinfectant and active ingredient for antiseptics, mouthwashes, and gargles. It also produces a lemony scent-a discovery made by ancient Athenian men-who made themselves elegant by rubbing their chest with a thyme scented lotion after bathing. In medieval times thyme mixed with honey was considered a potent remedy for pulmonary diseases. Inhalation of the herb was regarded as a remedy for melancholy and epilepsy.
It is shown in a series of stamps depicting medicinal plants issued by Bulgaria in 1966 (Stanley Gibbons 1858, Scott 1735).
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